PALO ALTO, Calif.--(BUSINESS WIRE)--StemCells, Inc. (NASDAQ:STEM) today announced that Martin McGlynn, President and Chief Executive Officer, will present at the UBS Global Life Sciences Conference in New York, NY on Wednesday, September 26, 2007 at 10:00 a.m. Eastern Time. Mr. McGlynn plans to report on the progress of the Company’s ongoing Phase 1 clinical trial in neuronal ceroid lipofuscinosis, plans for expanding the company’s Neural Program to additional indications, and an update on the company’s Liver Program, including a new initiative to develop a cell-based therapy for liver diseases. There will be a breakout session following the presentation at which Mr. McGlynn will be available to answer questions about the company.
